Document Detail


Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
MedLine Citation:
PMID:  6244327     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-five patients with acromegaly and 3 patients with gigantism underwent transsphenoidal microsurgery in an attempt to remove the tumor and preserve normal pituitary function whenever possible. An adenoma was identified and removed in 27 of 28 patients. Evaluation 3--6 months postoperatively revealed a GH level less than 5 ng/ml in 29 patients, 5--10 ng/ml in 4 patients and 11--29 ng/ml in 4 other patients. Dynamics of GH secretion were normal in 11 patients who had normal pituitary function and are considered cured. Two patients with low or undetectable GH levels are also considered cured at the expense of being hypopituitary. Three of 7 patients with normal basal GH levels but abnormal dynamics of GH secretion relapsed within 1 yr. Eleven of the 13 patients considered cured did not have extrasellar extension, while 14 of the 15 patients not cured had extrasellar extension. Five patients who were not cured with surgery received radiation therapy. Three patients were treated with an ergot derivative, Lergotrile mesylate, after surgery and radiation therapy failed to normalize GH levels. Transsphenoidal microsurgery is an optimal form of therapy for patients with acromegaly or gigantism, especially those with no extrasellar extension. Dynamics of GH secretion are very useful in evaluating the completeness of adenoma removal.
Authors:
B U Arafah; J S Brodkey; B Kaufman; M Velasco; A Manni; O H Pearson
Related Documents :
1184727 - Thyrotropin and prolactin pituitary reserve in the "empty sella syndrome".
17003007 - Growth and growth hormone secretion in paediatric cushing's disease.
19849747 - Clinical and biochemical characteristics of patients with thyroid-stimulating hormone-s...
3098457 - The long-term effects of megavoltage radiotherapy as sole or combined therapy for large...
18713507 - Decreased phosphorylation of stat-1, stat-4 and cytokine release in mdr-tb patients wit...
7628887 - Chemical cardioversion of atrial fibrillation with intravenous dofetilide.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  50     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1980 Mar 
Date Detail:
Created Date:  1980-05-30     Completed Date:  1980-05-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  578-85     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acromegaly / surgery*
Adenoma / surgery*
Adenoma, Acidophil / surgery
Adenoma, Chromophobe / surgery
Adolescent
Adult
Aged
Child
Female
Gigantism / surgery*
Growth Hormone / blood
Humans
Hypophysectomy
Male
Microsurgery
Middle Aged
Pituitary Neoplasms / surgery*
Postoperative Complications
Prolactin / blood
Chemical
Reg. No./Substance:
9002-62-4/Prolactin; 9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia ...
Next Document:  Enzyme immunoassay for measurement of antibodies to herpes simplex virus infection: comparison with ...